Form 4 Filing for Aquestive Therapeutics, Inc.

This filing details a derivative transaction by Abigail L. Jenkins, a director at Aquestive Therapeutics, Inc. On June 10, 2026, Ms. Jenkins was granted 50,500 non-qualified stock options for common stock, with a strike price of $3.99. These options have an exercise date of June 10, 2027, and an expiration date of June 10, 2036. The options vest fully on June 10, 2027, contingent upon Ms. Jenkins' continued service. The filing also includes a Power of Attorney document authorizing representatives to make electronic filings on behalf of Ms. Jenkins.